Personality disorders

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed, text revision (DSM-5-TR). Washington, DC: American Psychiatric Association; 2022.Full text

Storebø OJ, Stoffers-Winterling JM, Völlm BA, et al. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2020 May 4;5:CD012955.Full text  Abstract

Cristea IA, Gentili C, Cotet CD, et al. Efficacy of psychotherapies for borderline personality disorder: a systematic review and meta-analysis. JAMA Psychiatry. 2017 Apr 1;74(4):319-28.Full text  Abstract

Abbass AA, Kisely SR, Town JM, et al. Short-term psychodynamic psychotherapies for common mental disorders. Cochrane Database Syst Rev. 2014 Jul 1;(7):CD004687.Full text  Abstract

Herpertz SC, Zanarini M, Schulz CS, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders. World J Biol Psychiatry. 2007;8(4):212-44.Full text  Abstract

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed, text revision (DSM-5-TR). Washington, DC: American Psychiatric Association; 2022.Full text

2. World Health Organization. ICD-11 for mortality and morbidity statistics. 2022 [internet publication].Full text

3. Tomko RL, Trull TJ, Wood PK, et al. Characteristics of borderline personality disorder in a community sample: comorbidity, treatment utilization, and general functioning. J Pers Disord. 2014 Oct;28(5):734-50. Abstract

4. Samuels J, Eaton WW, Bienvenu OJ 3rd, et al. Prevalence and correlates of personality disorders in a community sample. Br J Psychiatry. 2002 Jun;180(6):536-42.Full text  Abstract

5. Crawford T, Cohen P, Johnson J, et al. Self-reported personality disorder in the children in the community sample: convergent and prospective validity in late adolescence and adulthood. J Pers Disord. 2005 Feb;19(1):30-52. Abstract

6. Grant B, Hasin D, Stinson F, et al. Prevalence, correlates, and disability of personality disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2004 Jul;65(7):948-58. Abstract

7. Trull TJ, Jahng S, Tomko RL, et al. Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders. J Pers Disord. 2010 Aug;24(4):412-26.Full text  Abstract

8. Volkert J, Gablonski TC, Rabung S. Prevalence of personality disorders in the general adult population in Western countries: systematic review and meta-analysis. Br J Psychiatry. 2018 Dec;213(6):709-15.Full text  Abstract

9. Lenzenweger MF, Lane MC, Loranger AW, et al. DSM-IV personality disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007 Sep 15;62(6):553-64.Full text  Abstract

10. Eaton NR, Greene AL. Personality disorders: community prevalence and socio-demographic correlates. Curr Opin Psychol. 2018 Jun;21:28-32. Abstract

11. Leichsenring F, Heim N, Leweke F, et al. Borderline personality disorder: a review. JAMA. 2023 Feb 28;329(8):670-9. Abstract

12. Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Arch Gen Psychiatry. 2001 Jun;58(6):590-6.Full text  Abstract

13. Coid J, Yang M, Tyrer P, et al. Prevalence and correlates of personality disorder in Great Britain. Br J Psychiatry. 2006 May;188(5):423-31.Full text  Abstract

14. McGilloway A, Hall RE, Lee T, et al. A systematic review of personality disorder, race and ethnicity: prevalence, aetiology and treatment. BMC Psychiatry. 2010 May 11;10:33.Full text  Abstract

15. Bohus M, Stoffers-Winterling J, Sharp C, et al. Borderline personality disorder. Lancet. 2021 Oct 23;398(10310):1528-40. Abstract

16. Reichborn-Kjennerud T. Genetics of personality disorders. Psychiatr Clin North Am. 2008 Sep;31(3):421-40. Abstract

17. Rhee S, Waldman I. Genetic and environmental influences on antisocial behavior: a meta-analysis of twin and adoption studies. Psychol Bull. 2002 May;128(3):490-529. Abstract

18. Torgersen S, Lygren S, Oien PA, et al. A twin study of personality disorders. Compr Psychiatry. 2000 Nov-Dec;41(6):416-25. Abstract

19. Bradley R, Jenei J, Westen D. Etiology of borderline personality disorder: disentangling the contributions of intercorrelated antecedents. J Nerv Ment Dis. 2005 Jan;193(1):24-31. Abstract

20. Coolidge F, Thede L, Jang K. Heritability of personality disorders in childhood: a preliminary investigation. J Pers Disord. 2001 Feb;15(1):33-40. Abstract

21. Reichborn-Kjennerud T, Czajkowski N, Neale MC, et al. Genetic and environmental influences on dimensional representations of DSM-IV cluster C personality disorders: a population-based multivariate twin study. Psychol Med. 2007 May;37(5):645-53. Abstract

22. Reichborn-Kjennerud T, Czajkowski N, Ystrøm E, et al. A longitudinal twin study of borderline and antisocial personality disorder traits in early to middle adulthood. Psychol Med. 2015 Oct;45(14):3121-31.Full text  Abstract

23. Kaffman A, Meaney MJ. Neurodevelopmental sequelae of postnatal maternal care in rodents: clinical and research implications of molecular insights. J Child Psychol Psychiatry. 2007 Mar-Apr;48(3-4):224-44. Abstract

24. Jang K, Dick D, Wolf H, et al. Psychosocial adversity and emotional instability: an application of gene-environment interaction models. Eur J Pers. 2005 Jun;19(4):359-72.Full text

25. Brent DA, Melhem N. Familial transmission of suicidal behavior. Psychiatr Clin North Am. 2008 Jun;31(2):157-77.Full text  Abstract

26. Martín-Blanco A, Ferrer M, Soler J, et al. The role of hypothalamus-pituitary-adrenal genes and childhood trauma in borderline personality disorder. Eur Arch Psychiatry Clin Neurosci. 2016 Jun;266(4):307-16. Abstract

27. Torgersen S, Czajkowski N, Jacobson K, et al. Dimensional representations of DSM-IV cluster B personality disorders in a population-based sample of Norwegian twins: a multivariate study. Psychol Med. 2008 Nov;38(11):1617-25. Abstract

28. Cattane N, Rossi R, Lanfredi M, et al. Borderline personality disorder and childhood trauma: exploring the affected biological systems and mechanisms. BMC Psychiatry. 2017 Jun 15;17(1):221.Full text  Abstract

29. Perez-Rodriguez MM, Bulbena-Cabré A, Bassir Nia A, et al. The neurobiology of borderline personality disorder. Psychiatr Clin North Am. 2018 Dec;41(4):633-50. Abstract

30. Anderson G. Pathoetiology and pathophysiology of borderline personality: role of prenatal factors, gut microbiome, mu- and kappa-opioid receptors in amygdala-PFC interactions. Prog Neuropsychopharmacol Biol Psychiatry. 2020 Mar 2;98:109782. Abstract

31. Stepp SD, Lazarus SA, Byrd AL. A systematic review of risk factors prospectively associated with borderline personality disorder: taking stock and moving forward. Personal Disord. 2016 Oct;7(4):316-23. Abstract

32. Belsky DW, Caspi A, Arseneault L, et al. Etiological features of borderline personality related characteristics in a birth cohort of 12-year-old children. Dev Psychopathol. 2012 Feb;24(1):251-65. Abstract

33. Skoglund C, Tiger A, Rück C, et al. Familial risk and heritability of diagnosed borderline personality disorder: a register study of the Swedish population. Mol Psychiatry. 2021 Mar;26(3):999-1008.Full text  Abstract

34. Witt SH, Streit F, Jungkunz M, et al. Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia. Transl Psychiatry. 2017 Jun 20;7(6):e1155.Full text  Abstract

35. Kendler K, Czajkowski N, Tambs K, et al. Dimensional representations of DSM-IV cluster A personality disorders in a population-based sample of Norwegian twins: a multivariate study. Psychol Med. 2006 Nov;36(11):1583-91. Abstract

36. Tienari P, Wynne LC, Läksy K, et al. Genetic boundaries of the schizophrenia spectrum: evidence from the Finnish Adoptive Family Study of Schizophrenia. Am J Psychiatry 2003 Sep;160(9):1587-94.Full text  Abstract

37. Essex MJ, Klein MH, Cho E, et al. Maternal stress beginning in infancy may sensitize children to later stress exposure: effects on cortisol and behavior. Biol Psychiatry. 2002 Oct 15;52(8):776-84. Abstract

38. Winsper C, Wolke D, Lereya T. Prospective associations between prenatal adversities and borderline personality disorder at 11-12 years. Psychol Med. 2015 Apr;45(5):1025-37. Abstract

39. Johnson JG, Cohen P, Brown J, et al. Childhood maltreatment increases risk for personality disorders during early adulthood. Arch Gen Psychiatry. 1999 Jul;56(7):600-6.Full text  Abstract

40. Eikenaes I, Egeland J, Hummelen B, et al. Avoidant personality disorder versus social phobia: the significance of childhood neglect. PLoS One. 2015 Mar 27;10(3):e0122846.Full text  Abstract

41. Spatz Widom C, Czaja SJ, Paris J. A prospective investigation of borderline personality disorder in abused and neglected children followed up into adulthood. J Pers Disord. 2009 Oct;23(5):433-46. Abstract

42. Mittal VA, Dhruv S, Tessner KD, et al. The relations among putative biorisk markers in schizotypal adolescents: minor physical anomalies, movement abnormalities, and salivary cortisol. Biol Psychiatry. 2007 May 15;61(10):1179-86. Abstract

43. New AS, Goodman M, Tribwasser J, et al. Recent advances in the biological study of personality disorders. Psychiatr Clin North Am. 2008 Sep;31(3):441-61,vii. Abstract

44. Johnson PA, Hurley RA, Benkelfat C, et al. Understanding emotion regulation in borderline personality disorder: contributions of neuroimaging. J Neuropsychiatry Clin Neurosci. 2003 Fall;15(4):397-402.Full text  Abstract

45. Schulze L, Schulze A, Renneberg B, et al. Neural correlates of affective disturbances: a comparative meta-analysis of negative affect processing in borderline personality disorder, major depressive disorder, and posttraumatic stress disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Mar;4(3):220-32. Abstract

46. Degasperi G, Cristea IA, Di Rosa E, et al. Parsing variability in borderline personality disorder: a meta-analysis of neuroimaging studies. Transl Psychiatry. 2021 May 24;11(1):314.Full text  Abstract

47. Friedel RO. Dopamine dysfunction in borderline personality disorder: a hypothesis. Neuropsychopharmacol. 2004 Jun;29(6):1029-39.Full text  Abstract

48. Herpertz SC, Bertsch K. A new perspective on the pathophysiology of borderline personality disorder: a model of the role of oxytocin. Am J Psychiatry. 2015 Sep 1;172(9):840-51.Full text  Abstract

49. Bertsch K, Schmidinger I, Neumann ID, et al. Reduced plasma oxytocin levels in female patients with borderline personality disorder. Horm Behav. 2013 Mar;63(3):424-9. Abstract

50. Johnson JG, Cohen P, Chen H, et al. Parenting behaviors associated with risk for offspring personality disorder during adulthood. Arch Gen Psychiatry. 2006 May;63(5):579-87.Full text  Abstract

51. Helgeland MI, Kjelsberg E, Torgersen S. Continuities between emotional and disruptive behavior disorders in adolescence and personality disorders in adulthood. Am J Psychiatry. 2005 Oct;162(10):1941-7.Full text  Abstract

52. Hahn SR, Thompson KS, Wills TA, et al. The difficult doctor-patient relationship: somatization, personality and psychopathology. J Clin Epidemiol. 1994 Jun;47(6):647-57. Abstract

53. Bax OK, Chartonas D, Parker J, et al. Personality disorder. BMJ. 2023 Sep 4;382:e050290.

54. Oldham JM, Skodol AE, Kellman HD, et al. Comorbidity of axis I and axis II disorders. Am J Psychiatry. 1995 Apr;152(4):571-8. Abstract

55. Rost KM, Akins RN, Brown FW, et al. The comorbidity of DSM-III-R personality disorders in somatization disorder. Gen Hosp Psychiatry. 1992 Sep;14(5):322-6. Abstract

56. Joiner T, Kalafat J, Draper J, et al. Establishing standards for the assessment of suicide risk among callers to the National Suicide Prevention Lifeline. Suicide Life Threat Behav. 2007 Jun;37(3):353-65.Full text  Abstract

57. Moran P, Leese M, Lee T, et al. Standardised Assessment of Personality - Abbreviated Scale (SAPAS): preliminary validation of a brief screen for personality disorder. Br J Psychiatry. 2003 Sep;183:228-32.Full text  Abstract

58. Hesse M, Moran P. Screening for personality disorder with the Standardised Assessment of Personality - Abbreviated Scale (SAPAS): further evidence of concurrent validity. BMC Psychiatry. 2010 Jan 28;10:10.Full text  Abstract

59. Gorwood P, Rouillon F, Even C, et al. Treatment response in major depression: effects of personality dysfunction and prior depression. Br J Psychiatry. 2010 Feb;196(2):139-42.Full text  Abstract

60. Morse JQ, Pilkonis PA. Screening for personality disorders. J Pers Disord. 2007 Apr;21(2):179-98.Full text  Abstract

61. Walters P, Moran P, Choudhury P, et al. Screening for personality disorder: a comparison of personality disorder assessment by patients and informants. Int J Methods Psychiatr Res. 2004;13(1):34-9.Full text  Abstract

62. Spitzer RL, Williams JB, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA. 1994 Dec 14;272(22):1749-56. Abstract

63. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13.Full text  Abstract

64. Kroenke K, Spitzer RL, Williams JB, et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007 Mar 6;146(5):317-25. Abstract

65. Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7.Full text  Abstract

66. Hirschfeld RM, Williams JB, Spitzer RL, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000 Nov;157(11):1873-5.Full text  Abstract

67. LeFevre ML; US Preventive Services Task Force. Screening for suicide risk in adolescents, adults, and older adults in primary care: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2014 May 20;160(10):719-26.Full text  Abstract

68. Whitlock EP, Polen MR, Green CA, et al. Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004 Apr 6;140(7):557-68.Full text  Abstract

69. Sharp C. Personality disorders. N Engl J Med. 2022 Sep 8;387(10):916-23.

70. Balint M. The doctor, his patient, and the illness. New York, NY: International Universities Press; 1957.

71. Devens M. Personality disorders. Prim Care. 2007 Sep;34(3):623-40. Abstract

72. Zaheer J, Links PS, Liu E. Assessment and emergency management of suicidality in personality disorders. Psychiatr Clin North Am. 2008 Sep;31(3):527-43. Abstract

73. Monk-Cunliffe J, Borschmann R, Monk A, et al. Crisis interventions for adults with borderline personality disorder. Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD009353.Full text  Abstract

74. Soloff PH, Lynch KG, Kelly TM, et al. Characteristics of suicide attempts of patients with major depressive episode and borderline personality disorder: a comparative study. Am J Psychiatry. 2000 Apr;157(4):601-8.Full text  Abstract

75. Apter A, Bleich A, King RA, et al. Death without warning? A clinical postmortem study of suicide in 43 Israeli adolescent males. Arch Gen Psychiatry. 1993 Feb;50(2):138-42. Abstract

76. Fenton WS, McGlashan TH, Victor BJ, et al. Symptoms, subtype and suicidality in patients with schizophrenia spectrum disorders. Am J Psychiatry. 1997 Feb;154(2):199-204. Abstract

77. Storebø OJ, Stoffers-Winterling JM, Völlm BA, et al. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2020 May 4;5:CD012955.Full text  Abstract

78. Duggan C, Huband N, Smailagic N, et al. The use of psychological treatments for people with personality disorder: a systematic review of randomized controlled trials. Pers Ment Health. 2007 Nov;1(2):95-125.Full text

79. Paris J. Clinical trials of treatment for personality disorders. Psychiatr Clin North Am. 2008 Sep;31(3):517-26. Abstract

80. Gunderson JG. Clinical practice. Borderline personality disorder. N Engl J Med. 2011 May 26;364(21):2037-42. Abstract

81. Cristea IA, Gentili C, Cotet CD, et al. Efficacy of psychotherapies for borderline personality disorder: a systematic review and meta-analysis. JAMA Psychiatry. 2017 Apr 1;74(4):319-28.Full text  Abstract

82. Gibbon S, Khalifa NR, Cheung NH, et al. Psychological interventions for antisocial personality disorder. Cochrane Database Syst Rev. 2020 Sep 3;9:CD007668.Full text  Abstract

83. Armelius BA, Andreassen TH. Cognitive-behavioral treatment for antisocial behavior in youth in residential treatment. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005650.Full text  Abstract

84. Simon W. Follow-up psychotherapy outcome of patients with dependent, avoidant and obsessive-compulsive personality disorders: a meta-analytic review. Int J Psychiatry Clin Pract. 2009;13(2):153-65. Abstract

85. Abbass AA, Kisely SR, Town JM, et al. Short-term psychodynamic psychotherapies for common mental disorders. Cochrane Database Syst Rev. 2014 Jul 1;(7):CD004687.Full text  Abstract

86. Dimeff LA, Koerner K, eds. Dialectical behavior therapy in clinical practice. New York, NY: The Guilford Press; 2007.

87. Duggan C, Huband N, Smailagic N, et al. The use of pharmacological treatments for people with personality disorder: a systematic review of randomized controlled trials. Pers Ment Health. 2008 Jul;2(3):119-70.Full text

88. Bateman AW, Gunderson J, Mulder R, et al. Treatment of personality disorder. Lancet. 2015 Feb 21;385(9969):735-43. Abstract

89. Hardoon S, Hayes J, Viding E, et al. Prescribing of antipsychotics among people with recorded personality disorder in primary care: a retrospective nationwide cohort study using The Health Improvement Network primary care database. BMJ Open. 2022 Mar 9;12(3):e053943.Full text  Abstract

90. Goldberg SC, Schulz SC, Schulz PM, et al. Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo. Arch Gen Psychiatry. 1986 Jul;43(7):680-6. Abstract

91. Koenigsberg HW, Reynolds D, Goodman M, et al. Risperidone in the treatment of schizotypal personality disorder. J Clinical Psychiatry. 2003 Jun;64(6):628-34. Abstract

92. Soloff PH, George A, Nathan RS, et al. Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo. Arch Gen Psychiatry. 1986 Jul;43(7):691-7. Abstract

93. Serban G, Siegel S. Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol. Am J Psychiatry. 1984 Nov;141(11):1455-8. Abstract

94. Markovitz PJ, Calabrese JR, Schulz SC, et al. Fluoxetine in the treatment of borderline and schizotypal personality disorders. Am J Psychiatry. 1991 Aug;148(8):1064-7. Abstract

95. Jensen HV, Andersen J. An open, noncomparative study of amoxapine in borderline disorders. Acta Psychiatrica Scandinavica. 1989 Jan;79(1):89-93. Abstract

96. Stoffers-Winterling JM, Storebø OJ, Pereira Ribeiro J, et al. Pharmacological interventions for people with borderline personality disorder. Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD012956.Full text  Abstract

97. National Institute for Health and Care Excellence. Borderline personality disorder: recognition and management. Jan 2009 [internet publication].Full text

98. Mercer D, Douglass AB, Links PS, et al. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms. J Pers Disord. 2009 Apr;23(2):156-74. Abstract

99. Ingenhoven T, Lafay P, Rinne T, et al. Effectiveness of pharmacotherapy for severe personality disorders: meta-analyses of randomized controlled trials. J Clin Psychiatry. 2010 Jan;71(1):14-25. Abstract

100. Crawford MJ, Sanatinia R, Barrett B, et al. Lamotrigine for people with borderline personality disorder: a RCT. Health Technol Assess. 2018 Apr;22(17):1-68.Full text  Abstract

101. Khalifa NR, Gibbon S, Völlm BA, et al. Pharmacological interventions for antisocial personality disorder. Cochrane Database Syst Rev. 2020 Sep 3;9:CD007667.Full text  Abstract

102. Sheard MH, Marini JL, Bridges CI, et al. The effect of lithium on impulsive aggressive behavior in man. Am J Psychiatry. 1976 Dec;133(12):1409-13. Abstract

103. Barratt ES, Kent TA, Bryant SG, et al. Controlled trial of phenytoin in impulsive aggression. J Clinical Psychopharmacol. 1991 Dec;11(6):388-9. Abstract

104. National Institute for Health and Care Excellence. Antisocial personality disorder: prevention and management. Mar 2013 [internet publication].Full text

105. Loranger AW, Sartorius N, Andreoli A, et al. The International Personality Disorder Examination. The World Health Organization/Alcohol, Drug Abuse, and Mental Health Administration international pilot study of personality disorders. Arch Gen Psychiatry. 1994 Mar;51(3):215-24. Abstract

106. Alden LE, Laposa JM, Taylor CT, et al. Avoidant personality disorder: current status and future directions. J Pers Disord. 2002 Feb;16(1):1-29. Abstract

107. Herpertz SC, Zanarini M, Schulz CS, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders. World J Biol Psychiatry. 2007;8(4):212-44.Full text  Abstract

108. Van Ameringen MA, Lane RM, WAlker JR, et al. Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study. Am J Psychiatry. 2001 Feb;158(2):275-81.Full text  Abstract

109. Pande AC, Feltner DE, Jefferson JW, et al. Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. J Clinical Psychopharmacol. 2004 Apr;24(2):141-9. Abstract

110. Pande AC, Davidson JR, Jefferson JW, et al. Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol. 1999 Aug;19(4):341-8. Abstract

111. Soloff PH. Symptom-oriented psychopharmacology for personality disorders. J Psych Prac. 1998 Jan;4(1):3-11.Full text

112. Soloff PH. Algorithms for pharmacological treatment of personality dimensions: symptom-specific treatments for cognitive-perceptual, affective, and impulse-behavioral dysregulation. Bull Menninger Clin. 1998 Spring;62(2):195-214. Abstract

113. Ripoll LH. Clinical psychopharmacology of borderline personality disorder: an update on the available evidence in light of the Diagnostic and Statistical Manual of Mental Disorders - 5. Curr Opin Psychiatry. 2012 Jan;25(1):52-8. Abstract

114. Bellino S, Bozzatello P, Blandamura A, et al. Antidepressants in the treatment of borderline personality disorder: a review of literature data [in Italian]. J Psychopathol. 2009;15(2):163-76.Full text

115. Kleber HD, Weiss RD, Anton RF Jr, et al; Work Group on Substance Use Disorders. Treatment of patients with substance use disorders: second edition. Am J Psychiatry. 2006 Aug;163(8 Suppl):5-82. Abstract

116. Rudd MD, Mandrusiak M, Joiner Jr TE. The case against no-suicide contracts: the commitment to treatment statement as a practice alternative. J Clin Psychol. 2006 Feb;62(2):243-51. Abstract

117. Gibbon S, Duggan C, Stoffers J, et al. Psychological interventions for antisocial personality disorder. Cochrane Database Syst Rev. 2010 Jun 16;(6):CD007668.Full text  Abstract

118. Reyes-López J, Ricardo-Garcell J, Armas-Castañeda G, et al. Clinical improvement in patients with borderline personality disorder after treatment with repetitive transcranial magnetic stimulation: preliminary results. Braz J Psychiatry. 2018 Jan-Mar;40(1):97-104.Full text  Abstract

119. Schulze L, Grove M, Tamm S, et al. Effects of transcranial direct current stimulation on the cognitive control of negative stimuli in borderline personality disorder. Sci Rep. 2019 Jan 23;9(1):332.Full text  Abstract

120. Zanarini MC, Frankenburg FR, Hennen J, et al. Prediction of the 10-year course of borderline personality disorder. Am J Psychiatry. 2006 May;163(5):827-32.Full text  Abstract

121. Bateman A, Fonagy P. Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatry. 1999 Oct;156(10):1563-9.Full text  Abstract

122. Gunderson JG, Stout RL, McGlashan TH, et al. Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study. Arch Gen Psychiatry. 2011 Aug;68(8):827-37.Full text  Abstract

123. Soloff PH, Fabio A, Kelly TM, et al. High-lethality status in patients with borderline personality disorder. J Pers Disord. 2005 Aug;19(4):386-99. Abstract

124. Oldham JM. Borderline personality disorder and suicidality. Am J Psychiatry. 2006 Jan;163(1):20-6.Full text  Abstract

125. McMain S. Effectiveness of psychosocial treatments on suicidality in personality disorders. Can J Psychiatry. 2007 Jun;52(6 Suppl 1):103S-14S. Abstract